|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
83
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
93
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
89
0
|
|
-
andrepharma3
2025-3-14
-
89
0
|
|
-
andrepharma3
2025-3-14
-
106
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
97
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
119
0
|
|
-
andrepharma3
2025-3-14
-
91
0
|
|
-
andrepharma3
2025-3-14
-
88
0
|